IL1B and Alzheimer disease: In addition, increased inflammatory mediators, such as tumour necrosis factor alpha and interleukin-1 beta (IL-1β), are correlated with cognitive deficits for patients with late-stage Alzheimer’s disease (Morimoto et al., 2011).